Seim Robin Gene's Form 4 filing
Omnicell, Inc.OMCL · filed Aug 10, 2021
- Accession no.
- 0001179110-21-008091
- Filed
- Aug 10, 2021
- Trade date
- Aug 9, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $1.01M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Seim Robin GeneCIK 0001351911 | Director, Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2021 | Common Stock | SSaleDisposed | −1,947 | $150.27F1 | −$292,575.69 | 34,788 | Direct | |
| Aug 9, 2021 | Common Stock | SSaleDisposed | −2,291 | $151.43F2 | −$346,926.13 | 32,497 | Direct | |
| Aug 9, 2021 | Common Stock | SSaleDisposed | −1,668 | $152.55F3 | −$254,453.4 | 30,829 | Direct | |
| Aug 9, 2021 | Common Stock | SSaleDisposed | −780 | $153.40F4 | −$119,652 | 30,049 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.00 to $150.985. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.045 to $152.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.21 to $153.165. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.225 to $153.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.